Immune mediated phenomena such as arthralgia or transient arthritis seems to be rare in IPEX as it affects 5.1% (2/39 patients) of the already reported FOXP3-IPEX patients. This evidence concerns the gene FOXP3 and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome.